Schafer Cullen Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,860
Closed -$658K 66
2020
Q4
$658K Hold
2,860
0.01% 174
2020
Q3
$727K Hold
2,860
0.01% 154
2020
Q2
$675K Hold
2,860
0.01% 151
2020
Q1
$580K Hold
2,860
0.01% 163
2019
Q4
$689K Hold
2,860
0.01% 171
2019
Q3
$553K Hold
2,860
0.01% 171
2019
Q2
$500K Hold
2,860
0.01% 172
2019
Q1
$543K Sell
2,860
-95
-3% -$18.1K 0.01% 172
2018
Q4
$575K Hold
2,955
0.01% 191
2018
Q3
$613K Hold
2,955
0.01% 177
2018
Q2
$545K Hold
2,955
0.01% 187
2018
Q1
$504K Buy
2,955
+480
+19% +$88.1K 0.01% 199
2017
Q4
$430K Buy
2,475
+95
+4% +$16.8K 0.01% 224
2017
Q3
$444K Hold
2,380
0.01% 220
2017
Q2
$410K Hold
2,380
0.01% 223
2017
Q1
$390K Buy
+2,380
New +$395K 0.01% 225

Other funds holding AMGN

Schafer Cullen Capital Management's AMGN Position: Q1 2021 in Review

Schafer Cullen Capital Management sold out of Amgen (AMGN) in Q1 2021, closing a stake of 2,860 shares — an estimated $658K sold.

Schafer Cullen Capital Management first reported a position in AMGN in Q1 2017 and held it in 16 quarters. The position peaked at $727K in Q3 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • Schafer Cullen Capital Management reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
  • Schafer Cullen Capital Management sold 2,860 Amgen shares in Q1 2021, an estimated $658K.
  • Schafer Cullen Capital Management first reported a position in Amgen in Q1 2017 and held it in 16 quarters.
  • Schafer Cullen Capital Management's Amgen position peaked at $727K in Q3 2020.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on Schafer Cullen Capital Management's 13F filing for Q1 2021, filed 10 May 2021.